El Hospital General Universitario de Albacete es un hospital público del Servicio de Salud de Castilla-La Mancha situado en la ciudad española de Albacete. Inaugurado en 1985 por el ministro de Sanidad Ernest Lluch, es uno de los principales hospitales de referencia de Castilla-La Mancha.

During the past decade, Complejo Hospitalario Universitario de Albacete conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 11 clinical trials were completed, i.e. on average, 21.6% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 8 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complejo Hospitalario Universitario de Albacete" #1 sponsor was "PETHEMA Foundation" with 17 trials, followed by "Spanish Breast Cancer Research Group" with 7 trials sponsored, "Complejo Hospitalario Universitario de Albacete" with 5 trials sponsored, "Fundación EPIC" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 52 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario Universitario de Albacete" #1 collaborator was "Celgene" with 3 trials as a collaborator, "Dynamic Science S.L." with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 2 trials as a collaborator and "Effice Servicios Para la Investigacion S.L." with 2 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario Universitario de Albacete" are "Coronary Artery Disease" (8 trials), "Acute Lymphoblastic Leukemia" (4 trials), "Multiple Myeloma" (4 trials), "Acute Myeloid Leukemia" (3 trials) and "Breast Cancer" (3 trials). Many other conditions were trialed in "Complejo Hospitalario Universitario de Albacete" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario Universitario de Albacete" are "Drug" (58 trials), "Other" (16 trials), "Device" (7 trials), "Procedure" (7 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Cyclophosphamide" (5 trials), "Dexamethasone" (5 trials), "Prednisone" (4 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario Universitario de Albacete" are 87 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Complejo Hospitalario Universitario de Albacete". 2 are not yet recruiting, 21 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Complejo Hospitalario Universitario de Albacete, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario Universitario de Albacete, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 10 trials that are defined as “Not Applicable".

Complejo Hospitalario Universitario de Albacete has several departments that took part in Clinical trials: "Hospital General Universitario de Albacete; Servicio de Neurología" - 3 trials, "Complejo Hospitalario Universitario de Albacete; Servicio de Oncologia" - 3 trials